Montrusco Bolton Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-70,389
Closed -$53.7M 75
2025
Q3
$53.7M Buy
70,389
+10,621
+18% +$7.9M 0.63% 29
2025
Q2
$46.6M Buy
+59,768
New +$46.4M 0.52% 30
2015
Q4
Sell
-4,680
Closed -$392K 81
2015
Q3
$392K Buy
4,680
+480
+11% +$40.5K 0.03% 68
2015
Q2
$351K Buy
+4,200
New +$320K 0.03% 68

Other funds holding LLY

Montrusco Bolton Investments's LLY Position: Q4 2025 in Review

Montrusco Bolton Investments sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 70,389 shares — an estimated $53.7M sold.

Montrusco Bolton Investments first reported a position in LLY in Q2 2015 and held it in 4 quarters. The position peaked at $53.7M in Q3 2025. 4,430 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Montrusco Bolton Investments reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Montrusco Bolton Investments sold 70,389 Eli Lilly shares in Q4 2025, an estimated $53.7M.
  • Montrusco Bolton Investments first reported a position in Eli Lilly in Q2 2015 and held it in 4 quarters.
  • Montrusco Bolton Investments's Eli Lilly position peaked at $53.7M in Q3 2025.
  • 4,430 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Montrusco Bolton Investments's 13F filing for Q4 2025, filed 29 Jan 2026.